首页> 外国专利> NOVEL LUNG CANCER CELL LINE DERIVED FROM A PATIENT, AND A KIT CONTAINING THE SAME FOR SCREENING A LUNG CANCER THERAPEUTIC AGENT

NOVEL LUNG CANCER CELL LINE DERIVED FROM A PATIENT, AND A KIT CONTAINING THE SAME FOR SCREENING A LUNG CANCER THERAPEUTIC AGENT

机译:源自患者的新型肺癌细胞系,以及包含相同筛查肺癌治疗剂的试剂盒

摘要

PURPOSE: A novel lung cancer cell line and a kit containing the same for screening a lung cancer therapeutic agent are provided to ensure the trait of lung cancer cells and to develop a customized therapeutic agent.;CONSTITUTION: A method for screening a lung cancer therapeutic agent comprises: a step of culturing a novel lung cancer cell line, SMC-L001(deposit number: KCLRF-BP-00274); a step of treating the lung cell line with a candidate material as a lung cancer therapeutic agent; a step of culturing the treated lung cancer cell line and measuring morphological, physiological, or genetic change of the lung cancer cell line; and a step of determining whether the candidate material is used as a lung cancer therapeutic agent. A kit for screening the lung cancer therapeutic agent contains the lung cancer cell line.;COPYRIGHT KIPO 2013
机译:目的:提供一种新型的肺癌细胞系以及用于筛选肺癌治疗剂的试剂盒,以确保肺癌细胞的特性并开发定制化的治疗剂。;构成:一种筛选肺癌治疗剂的方法该试剂包括:培养新的肺癌细胞系SMC-L001(保藏号:KCLRF-BP-00274)的步骤;用候选物质作为肺癌治疗剂治疗肺细胞系的步骤;培养经处理的肺癌细胞系并测量肺癌细胞系的形态,生理或遗传变化的步骤;确定候选材料是否用作肺癌治疗剂的步骤。包含肺癌细胞系的肺癌治疗剂筛选试剂盒。; COPYRIGHT KIPO 2013

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号